Corcept Therapeutics said on Monday its experimental drug in combination with chemotherapy helped delay progression of a type ...

Almost 7,000 trees have been planted at an arboretum by community groups, schools and colleges since last year. From November ...

W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the ...

Not getting enough of deeper stages of sleep raises the risk of brain deterioration associated with Alzheimer’s disease, a ...

The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a genetically inherited risk ...

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

Task: Navigating an autoimmune condition Occupation: CEO and co-founder of WellTheory, a platform for autoimmune care ...

Ella Rhian had never experienced any stomach problems before and lived a normal, healthy life. Then, in September 2023, the ...

Eli Lilly And Co (NYSE:LLY), on Sunday, announced positive Phase 2 results for lepodisiran, an investigational small ...

Drinking sugar-sweetened beverages may increase your risk of heart disease. These drinks are easy to overconsume and provide ...